Subscribe

Kansai Nerolac Paints Limited (KANSAINER.NS)

INR202.93 +5.90 (+2.99%)
IN NSE Basic Materials Chemicals - Specialty
Address Marathon Futurex 400013
Mumbai, MH, IN
CEO Pravin Digambar Chaudhari
Website nerolac.com
IPO 2002-07-01
ISIN INE531A01024

Explore sections of this company profile

Also trades on Bombay Stock Exchange · KANSAINER.BO (INR) National Stock Exchange of India · KANSAINER.NS (INR)
Description

Kansai Nerolac Paints Limited manufactures and supplies paints, varnishes, enamels, and lacquers in India. It offers interior and exterior wall paints, wood coatings, metal enamel paints, and ancillary paints, as well as adhesives and waterproofing products; interior textures; general industrial, powder, coil, automotive, auto refinish, and floor coatings; wood finishes, waterproofing solutions, and construction chemicals; and decorative and soldier paints. The company also provides painters, background check, guidance, color consultation, on-site sanitation, quotation, and color selection tools services. It serves residential, commercial, retail, industrial, governmental, and institutional customers, as well as automotive, consumer durables, machinery, equipment, and structural industries. The company was formerly known as Goodlass Nerolac Paints Limited and changed its name to Kansai Nerolac Paints Limited in April 2006. The company was incorporated in 1920 and is headquartered in Mumbai, India. Kansai Nerolac Paints Limited is a subsidiary of Kansai Paint Co., Ltd.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
INR202.93 +5.90 (+2.99%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
575.4K
Beta
0.29
Float Shares
201.27M
Free Float %
24.9%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-1.61% -0.54% +11.65% +5.64% -12.91% -9.18% -17.81% -23.33% -42.66% +7.17% +6,865.15%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
202.93
DCF (Unlevered) 840.48 +314.2%
DCF (Levered) 1,354.67 +567.6%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 44% Bullish
Rating 2026-05 Change
Strong Buy 4 0
Buy 3 +1
Hold 5 -1
Sell 1 0
Strong Sell 3 0
Quality scores
Altman Z-Score
7.02
Safe zone
Piotroski F-Score
4 / 9
Average
MOAT Score
5 / 10
Developing
Composite Rating
A-
Overall Score
4 / 5
High
DCF Score
5 / 5
High
ROE Score
4 / 5
High
ROA Score
5 / 5
High
D/E Score
2 / 5
Medium
P/E Score
2 / 5
Medium
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
  • ✗
    Revenue growth Chemicals - Specialty: +4.7%
    +3.4% Q1'26: +9.7% (vs Q1'25)
  • ✗
    EPS growth Chemicals - Specialty: +13.2%
    -48.4% Q1'26: +3.7% (vs Q1'25)
  • ✓
    FCF margin FCF growth · Chemicals - Specialty: +44.1%
    +7.8% Q1'26: +5.0% (vs Q1'25)
  • ✗
    EBIT margin Chemicals - Specialty: +8.8%
    +9.3% ★ Q1'26: +8.0% (vs Q1'25)
  • ✗
    ROIC Chemicals - Specialty: +5.6%
    +12.3% ★ Q1'26: +9.8% (vs Q1'25)
  • ✗
    Share dilution Chemicals - Specialty: +0.1%
    +0.0% Q1'26: -0.2% (vs Q1'25)
  • ✓
    Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×
    0.31× ★ Q1'26: 0.35× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
▶ WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.25) × ERP
WACC = 98% × Ke + 2% × Kd (10.7%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
—
Intrinsic value (base): 807.31 Current price: 202.93
Enterprise Value: — Equity Value: — Terminal Value: — TV as % of EV: —

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Mar 2009
actual 		Mar 2010
actual 		Mar 2011
actual 		Mar 2012
actual 		Mar 2013
actual 		Mar 2014
actual 		Mar 2015
actual 		Mar 2016
actual 		Mar 2017
actual 		Mar 2018
actual 		Mar 2019
actual 		Mar 2020
actual 		Mar 2021
actual 		Mar 2022
actual 		Mar 2023
actual 		Mar 2024
actual 		Mar 2025
actual 		Mar 2026
12 Rev. Ana.
11 EPS Ana. 		Mar 2027
13 Rev. Ana.
12 EPS Ana. 		Mar 2028
13 Rev. Ana.
13 EPS Ana. 		Mar 2029
9 Rev. Ana.
8 EPS Ana.
Revenue
13.75B
est: 13.80B (-0.4%)
17.06B
est: 16.62B (+2.7%)
21.27B
est: 22.28B (-4.5%)
25.86B
est: 26.00B (-0.5%)
27.84B
est: 29.53B (-5.7%)
31.02B
est: 32.55B (-4.7%)
34.89B
est: 36.47B (-4.3%)
37.57B
est: 38.49B (-2.4%)
40.43B
est: 41.48B (-2.5%)
46.46B
est: 45.76B (+1.5%)
54.07B
est: 52.50B (+3.0%)
52.64B
est: 51.89B (+1.4%)
50.41B
est: 48.20B (+4.6%)
62.82B
est: 62.76B (+0.1%)
75.05B
est: 73.93B (+1.5%)
77.68B
est: 78.86B (-1.5%)
77.87B
est: 78.42B (-0.7%)
80.21B
79.39B – 81.93B
+2.3% YoY
88.31B
84.57B – 90.73B
+10.1% YoY
94.47B
87.30B – 97.86B
+7.0% YoY
101.64B
95.57B – 104.87B
+7.6% YoY
EBITDA
1.80B
est: 1.94B (-7.1%)
2.84B
est: 2.39B (+18.6%)
3.13B
est: 4.03B (-22.3%)
3.62B
est: 4.18B (-13.5%)
4.70B
est: 4.37B (+7.5%)
3.77B
est: 5.32B (-29.1%)
4.73B
est: 4.24B (+11.4%)
5.85B
est: 5.33B (+9.8%)
7.37B
est: 12.17B (-39.4%)
8.65B
est: 10.63B (-18.6%)
8.13B
est: 10.83B (-24.9%)
8.30B
est: 8.44B (-1.6%)
9.01B
est: 7.21B (+25.1%)
6.74B
est: 8.85B (-23.8%)
8.44B
est: 10.01B (-15.7%)
17.81B
est: 11.63B (+53.1%)
17.11B
est: 14.25B (+20.0%)
15.13B
14.97B – 15.45B
+6.1% YoY
16.65B
15.95B – 17.11B
+10.1% YoY
17.81B
16.46B – 18.45B
+7.0% YoY
19.17B
18.02B – 19.78B
+7.6% YoY
EBIT
1.42B
est: 1.33B (+6.5%)
2.40B
est: 1.50B (+59.4%)
2.64B
est: 2.94B (-10.3%)
3.05B
est: 3.11B (-1.9%)
4.23B
est: 3.19B (+32.5%)
3.12B
est: 4.48B (-30.4%)
4.04B
est: 3.37B (+19.9%)
5.16B
est: 4.16B (+24.1%)
6.67B
est: 5.36B (+24.4%)
7.88B
est: 7.65B (+2.9%)
7.07B
est: 8.32B (-15.1%)
6.88B
est: 6.39B (+7.6%)
7.36B
est: 5.85B (+25.8%)
5.04B
est: 7.18B (-29.8%)
6.64B
est: 8.12B (-18.3%)
15.90B
est: 9.44B (+68.4%)
15.09B
est: 12.44B (+21.3%)
12.70B
12.57B – 12.97B
+2.1% YoY
13.98B
13.39B – 14.36B
+10.1% YoY
14.96B
13.82B – 15.49B
+7.0% YoY
16.09B
15.13B – 16.60B
+7.6% YoY
Net Income
985.89M
est: 1.11B (-10.8%)
1.66B
est: 1.24B (+33.8%)
2.06B
est: 2.22B (-7.1%)
2.16B
est: 2.40B (-10.2%)
2.93B
est: 2.45B (+19.6%)
2.08B
est: 3.23B (-35.6%)
2.74B
est: 2.32B (+18.0%)
9.01B
est: 2.98B (+202.4%)
5.08B
est: 9.36B (-45.7%)
5.14B
est: 5.84B (-11.9%)
4.53B
est: 5.98B (-24.2%)
5.21B
est: 4.48B (+16.4%)
5.30B
est: 4.60B (+15.1%)
3.59B
est: 5.65B (-36.5%)
4.74B
est: 6.39B (-25.9%)
11.85B
est: 7.43B (+59.6%)
11.43B
est: 6.47B (+76.6%)
6.66B
6.58B – 7.25B
+2.8% YoY
7.16B
6.99B – 7.74B
+7.7% YoY
7.97B
7.66B – 9.02B
+11.3% YoY
8.70B
8.03B – 9.06B
+9.2% YoY
SGA
—
est: 743.24M (-100.0%)
—
est: 1.49B (-100.0%)
—
est: 1.92B (-100.0%)
—
est: 2.03B (-100.0%)
4.26B
est: 4.13B (+3.2%)
2.51B
est: 3.45B (-27.3%)
3.15B
est: 3.85B (-18.2%)
4.32B
est: 6.01B (-28.2%)
5.11B
est: 6.23B (-18.0%)
5.54B
est: 8.11B (-31.7%)
6.03B
est: 9.04B (-33.3%)
6.16B
est: 8.89B (-30.7%)
4.93B
est: 8.14B (-39.4%)
6.14B
est: 9.99B (-38.6%)
6.95B
est: 11.30B (-38.5%)
8.55B
est: 13.13B (-34.9%)
8.90B
est: 9.13B (-2.5%)
9.32B
9.22B – 9.52B
+2.1% YoY
10.26B
9.82B – 10.54B
+10.1% YoY
10.98B
10.14B – 11.37B
+7.0% YoY
11.81B
11.10B – 12.18B
+7.6% YoY
EPS
1.22
est: 1.85 (-33.9%)
2.05
est: 2.96 (-30.8%)
2.55
est: 4.28 (-40.4%)
2.67
est: 4.15 (-35.7%)
3.63
est: 4.08 (-11.1%)
2.57
est: 4.03 (-36.3%)
3.39
est: 3.58 (-5.4%)
11.15
est: 4.44 (+150.9%)
6.29
est: 6.14 (+2.5%)
6.36
est: 6.69 (-5.0%)
5.60
est: 6.03 (-7.1%)
6.45
est: 7.10 (-9.1%)
6.55
est: 6.86 (-4.5%)
4.44
est: 5.87 (-24.4%)
5.86
est: 6.38 (-8.2%)
14.66
est: 8.51 (+72.4%)
14.14
est: 7.93 (+78.3%)
8.22
8.12 – 8.96
+3.6% YoY
8.85
8.63 – 9.55
+7.7% YoY
9.84
9.46 – 11.14
+11.3% YoY
10.75
9.92 – 11.19
+9.2% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-07 A- 4/5 5/5 4/5 5/5 2/5 2/5 3/5
2026-05-06 C 2/5 5/5 1/5 1/5 1/5 2/5 1/5
2026-05-05 C 2/5 5/5 1/5 1/5 1/5 2/5 1/5
2026-05-04 C 2/5 5/5 1/5 1/5 1/5 2/5 1/5
2026-04-30 C 2/5 5/5 1/5 1/5 1/5 2/5 1/5
2026-04-29 C 2/5 5/5 1/5 1/5 1/5 2/5 1/5
2026-04-28 C 2/5 5/5 1/5 1/5 1/5 2/5 1/5
2026-04-27 C 2/5 5/5 1/5 1/5 1/5 2/5 1/5
2026-04-24 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-04-23 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-04-22 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-04-21 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-04-20 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-04-17 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-04-16 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
386.22M
OE per share TTM
0.48
Owner's Yield
0.23%
Maintenance CapEx ratio
4.32%
Maint CapEx / Avg PPE
33.0%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock Held by 21 ETFs in our universe
# ETF Weight Est. AUM exposure TER
1 Vanguard Emerging Markets Ex-China ETF VEXC 0.01% 14.9K 0.07%
2 Schwab Emerging Markets Equity ETF SCHE 0.00% 566.3K 0.06%
3 Vanguard FTSE Asia ex Japan Shares Index ETF VAE.AX 0.00% 24.7K 0.40%
4 Vanguard FTSE Emerging Markets All Cap Index ETF VEE.TO 0.00% 123.3K 0.26%
5 Vanguard FTSE Emerging Markets Shares ETF VGE.AX 0.00% 54.7K 0.48%
6 Vanguard FTSE Emerging Markets ETF VWO 0.00% 6.08M 0.06%
7 Vanguard FTSE Emerging Markets UCITS ETF (USD) Accumulating VFEA.L 0.00% 196.9K 0.17%
8 Vanguard FTSE Emerging Markets UCITS ETF (USD) Distributing VDEM.L 0.00% 196.9K 0.17%
9 Vanguard All-World ex-US Shares Index ETF VEU.AX 0.00% 49.7K 0.04%
10 Vanguard FTSE All-World ex-US ETF VEU 0.00% 1.07M 0.04%

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
1.93M
Shares Outstanding
808.66M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Hirokazu Kotera Executive Director 5M male
Debashish Vanikar CEO of Nerofix Pvt. Ltd & Head of Construction Chemicals — male
G. T. Govindarajan Company Secretary & Compliance Officer — male
Jason S. Gonsalves Director of Corporate Planning, IT & Materials — male
Laxman Nikam Chief Technology Officer — male
Pravin Digambar Chaudhari MD & Director — male
Ram Mehrotra Chief Business Officer - Decorative Sales — male
Rohit Malkani Chief Strategy & Customer Officer — male
Sudhir Rane Chief Human Resource Officer — male
Abhijit Natoo Chief Manufacturing Officer — male
Yash Ahuja Chief Financial Officer & Chief Risk Officer — male
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings history

Earnings reports

Stock splits

Related companies

Largest companies in Chemicals - Specialty